From: Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy
 | Progression (n = 21) | Non-progression (n = 170) | P |
---|---|---|---|
Age, years | 53.3 ± 15.4 | 40.0 ± 14.4 | 0.001 |
Male, n (%) | 11 (52.4) | 74 (43.5) | 0.44 |
HTN, n (%) | 16 (76.2) | 61 (35.9) | < 0.001 |
DM, n (%) | 2 (9.5) | 9 (5.3) | 0.43 |
BMI, kg/m2 | 24.3 ± 3.3 | 23.9 ± 3.3 | 0.42 |
Albumin, g/dL | 3.7 ± 0.4 | 3.9 ± 0.6 | 0.01 |
IgA, mg/dL | 336.6 ± 88.5 | 304.5 ± 104.9 | 0.07 |
eGFR, ml/min/1.73 m2 | 55.9 ± 34.9 | 86.9 ± 32.7 | < 0.001 |
Urine PCR, g/gCr | 2.7 ± 2.3 | 1.4 ± 1.8 | < 0.001 |
Use of ARB or ACEi, n (%) | 16 (76.2) | 124 (72.9) | 0.75 |
Use of immunosuppressant, n (%) | 12 (57.1) | 101 (59.4) | 0.84 |
Oxford classification M | Â | Â | 0.76 |
0 | 11 (52.4) | 95 (55.9) | Â |
1 | 10 (47.6) | 75 (44.1) | Â |
Oxford classification E | Â | Â | 0.68 |
0 | 16 (76.2) | 136 (80.0) | Â |
1 | 5 (76.9) | 34 (20.0) | Â |
Oxford classification S | Â | Â | 0.80 |
0 | 13 (61.9) | 110 (64.7) | Â |
1 | 8 (38.1) | 60 (35.3) | Â |
Oxford classification T | Â | Â | 0.96 |
0 | 18 (85.7) | 145 (85.3) | Â |
1, 2 | 3 (14.3) | 25 (14.7) | Â |
Oxford classification C | Â | Â | 0.92 |
0 | 17 (81.0) | 145 (85.3) | Â |
1, 2 | 4 (9.0) | 24 (14.7) | Â |